Relation of Metabolic Rate of Omeprazole and Eradication of Helicobacter Pylori Infection
Status:
Completed
Trial end date:
1998-02-01
Target enrollment:
Participant gender:
Summary
The aims of this study are (1) to evaluate the prevalence rate of PM of CYP2C19 in our
country; (2) to evaluate the efficacy of dual therapy with different dose of omeprazole and
amoxicillin; (3) to judge the relationship of genotype of CYP2C19 and the eradication rate of
dual therapy in the peptic ulcer patients; (4) to try to find out a predictor of success of
dual therapy and an optimal dose of dual therapy as first-line and rescue anti-Helicobacter
pylori regimen.